Department Of Health
January 10
09:30
2025
class="gem-c-govspeak govuk-govspeak gem-c-govspeak--direction-ltr govuk-!-margin-bottom-0">
This document sets out theNHSs aggregate net sales and payment information on pharmaceuticals for the2019 voluntary scheme for branded medicines pricing and access(VPAS).
VPASis an agreement between the Department for Health and Social Care,NHSEngland and the Association of the British Pharmaceutical Industry that aims to:
- improve patient access to medicines by getting the best value and most effective medicines into use more quickly
- keep the branded medicine bill affordable for theNHSthrough a cap in growth of branded sales
- support innovation and a successful life sciences industry in theUK